Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 May 18;12(5):e0177894.
doi: 10.1371/journal.pone.0177894. eCollection 2017.

Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome

Affiliations

Predictive features of chronic kidney disease in atypical haemolytic uremic syndrome

Matthieu Jamme et al. PLoS One. .

Abstract

Chronic kidney disease (CKD) is a frequent and serious complication of atypical haemolytic uremic syndrome (aHUS). We aimed to develop a simple accurate model to predict the risk of renal dysfunction in aHUS based on clinical and biological features available at hospital admission. Renal function at 1-year follow-up, based on an estimated glomerular filtration rate < 60mL/min/1.73m2 as assessed by the Modification of Diet in Renal Disease equation, was used as an indicator of significant CKD. Prospectively collected data from a cohort of 156 aHUS patients who did not receive eculizumab were used to identify predictors of CKD. Covariates associated with renal impairment were identified by multivariate analysis. The model performance was assessed and a scoring system for clinical practice was constructed from the regression coefficient. Multivariate analyses identified three predictors of CKD: a high serum creatinine level, a high mean arterial pressure and a mildly decreased platelet count. The prognostic model had a good discriminative ability (area under the curve = .84). The scoring system ranged from 0 to 5, with corresponding risks of CKD ranging from 18% to 100%. This model accurately predicts development of 1-year CKD in patients with aHUS using clinical and biological features available on admission. After further validation, this model may assist in clinical decision making.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: Paul Coppo is a member of the advisory board for Alexion, Octapharma and Ablynx. Eric Rondeau is a member of the advisory board for Alexion. The others authors have declared that no competing interests exist. This does not alter our adherence to PLOS ONE policies on sharing data and materials.

Figures

Fig 1
Fig 1. ROC curve.
Fig 2
Fig 2. Probability of CKD according to the prognostic score.

References

    1. George JN, Nester CM. Syndromes of Thrombotic Microangiopathy. N Engl J Med. 2014. August 14;371(7):654–66. 10.1056/NEJMra1312353 - DOI - PubMed
    1. Tarr PI, Gordon CA, Chandler WL. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet Lond Engl. 2005. March 19;365(9464):1073–86. - PubMed
    1. Fakhouri F, Frémeaux-Bacchi V, Loirat C. Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy. Eur J Intern Med. 2013. September;24(6):492–5. 10.1016/j.ejim.2013.05.008 - DOI - PubMed
    1. Noris M, Caprioli J, Bresin E, Mossali C, Pianetti G, Gamba S, et al. Relative Role of Genetic Complement Abnormalities in Sporadic and Familial aHUS and Their Impact on Clinical Phenotype. Clin J Am Soc Nephrol. 2010. October 1;5(10):1844–59. 10.2215/CJN.02210310 - DOI - PMC - PubMed
    1. Fremeaux-Bacchi V, Fakhouri F, Garnier A, Bienaimé F, Dragon-Durey M-A, Ngo S, et al. Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults. Clin J Am Soc Nephrol CJASN. 2013. April;8(4):554–62. 10.2215/CJN.04760512 - DOI - PMC - PubMed